[1]
Tan, J. 2023. Comparing the Efficacy and Safety of the Pfizer BNT162b2 Vaccine with Other Alternatives Under COVID-19. Highlights in Science, Engineering and Technology. 74, (Dec. 2023), 822–828. DOI:https://doi.org/10.54097/4dy5rk83.